IMC Chicago
NVAX icon

IMC Chicago’s Novavax NVAX Stock Holding History

IMC Chicago’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Sell
248,100
-126,000
-34% -$1.14M ﹤0.01% 2560
2025
Q4 		$2.51M Sell
374,100
-53,600
-13% -$404K ﹤0.01% 2238
2025
Q3 		$3.71M Sell
427,700
-113,100
-21% -$880K ﹤0.01% 1788
2025
Q2 		$3.41M Buy
540,800
+291,000
+116% +$1.93M ﹤0.01% 1640
2025
Q1 		$1.6M Buy
249,800
+157,400
+170% +$1.3M ﹤0.01% 1942
2024
Q4 		$743K Sell
92,400
-97,500
-51% -$940K ﹤0.01% 2543
2024
Q3 		$2.4M Sell
189,900
-26,600
-12% -$343K ﹤0.01% 1560
2024
Q2 		$2.74M Buy
216,500
+98,900
+84% +$995K ﹤0.01% 1382
2024
Q1 		$562K Sell
117,600
-131,700
-53% -$611K ﹤0.01% 1991
2023
Q4 		$1.2M Sell
249,300
-23,700
-9% -$145K ﹤0.01% 1375
2023
Q3 		$1.98M Buy
273,000
+39,600
+17% +$316K ﹤0.01% 987
2023
Q2 		$1.73M Sell
233,400
-338,600
-59% -$2.66M ﹤0.01% 924
2023
Q1 		$3.96M Buy
572,000
+67,000
+13% +$616K ﹤0.01% 685
2022
Q4 		$5.19M Buy
505,000
+71,400
+16% +$1.26M 0.01% 601
2022
Q3 		$7.89M Buy
433,600
+113,500
+35% +$4.92M 0.01% 482
2022
Q2 		$16.5M Sell
320,100
-231,500
-42% -$12M 0.02% 325
2022
Q1 		$40.6M Sell
551,600
-94,700
-15% -$8.44M 0.04% 200
2021
Q4 		$92.5M Buy
646,300
+279,200
+76% +$48M 0.08% 107
2021
Q3 		$76.1M Buy
367,100
+6,200
+2% +$1.37M 0.08% 122
2021
Q2 		$76.6M Buy
360,900
+106,700
+42% +$19.5M 0.09% 117
2021
Q1 		$46.1M Buy
254,200
+13,900
+6% +$2.77M 0.07% 158
2020
Q4 		$26.8M Sell
240,300
-179,400
-43% -$19.1M 0.03% 215
2020
Q3 		$45.5M Buy
419,700
+260,300
+163% +$31.7M 0.07% 103
2020
Q2 		$13.3M Buy
+159,400
New +$6.1M 0.03% 217

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's NVAX Position: Q1 2026 in Review

IMC Chicago sold out of Novavax (NVAX) in Q1 2026, closing a stake of 78,083 shares — an estimated $708K sold.

IMC Chicago first reported a position in NVAX in Q2 2020 and held it in 10 quarters. The position peaked at $11.1M in Q3 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • IMC Chicago reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 78,083 Novavax shares in Q1 2026, an estimated $708K.
  • IMC Chicago first reported a position in Novavax in Q2 2020 and held it in 10 quarters.
  • IMC Chicago's Novavax position peaked at $11.1M in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.